PALI PALISADE BIO, INC.
Price Chart
Executive Summary
Palisade Bio's $300M universal shelf registration (File No. 333-295815) became effective on May 21, 2026, enabling the company to offer and sell securities at any time. The company had $132.6M in cash as of March 31, 2026, and management has stated existing cash funds operations through key Phase 2 readouts in 2H 2027 and early 2028, suggesting this is an opportunistic shelf filing rather than an imminent dilutive event.
Actionable Insight
Monitor for any subsequent prospectus supplement or takedown notice, which would signal an actual offering. The shelf becoming effective is a procedural step; the stock is unlikely to react until a specific offering is announced.
Key Facts
- Shelf registration (File No. 333-295815) declared effective on May 21, 2026.
- Company reported $132.6M in cash as of March 31, 2026.
- Management states existing cash funds operations through Phase 2 readouts in 2H 2027 and early 2028.
- Shelf provides maximum flexibility for future capital raises but no immediate offering announced.
Financial Impact
Up to $300M in potential future offerings, but no immediate dilution as no takedown has occurred.
Risk Factors
- Potential future dilution if the company conducts an offering under the shelf.
- Market may perceive shelf effectiveness as overhang, especially for a pre-revenue biotech.
Market Snapshot
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-001731 |
| Document: 9999999995-26-001731-index.html | 9999999995-26-001731 |
| Document: 9999999995-26-001731.txt | 9999999995-26-001731 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 11, 2026
1d ago
|
8-K
| $1.79 awaiting T+5 | awaiting T+5 | — | $1.71 (−4.20%) |
|
May 22, 2026
22d ago
|
EFFECT
| $1.95 $2.08 | ▲ +6.67% | ▲ +5.01% | $1.71 (−12.31%) |
|
May 12, 2026
4w ago
|
S-3
| $1.87 $1.81 | ▼ −3.21% | ▼ −2.05% | $1.71 (−8.56%) |
|
Apr 29, 2026
6w ago
|
DEFA14A
| $2.00 $1.99 | ▼ −0.50% | ▼ −2.23% | $1.71 (−14.50%) |
|
Apr 2, 2026
10w ago
|
8-K
| $1.89 $1.82 | ▼ −3.70% | ▼ −7.32% | $1.71 (−9.52%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access